Free-jet acoustic investigation of high-radius-ratio coannular plug nozzles

The experimental and analytical results of a scale model simulated flight acoustic exploratory investigation of high radius ratio coannular plug nozzles with inverted velocity and temperature profiles are summarized. Six coannular plug nozzle configurations and a baseline convergent conical nozzle were tested for simulated flight acoustic evaluation. The nozzles were tested over a range of test conditions that are typical of a Variable Cycle Engine for application to advanced high speed aircraft. It was found that in simulate flight, the high radius ratio coannular plug nozzles maintain their jet noise and shock noise reduction features previously observed in static testing. The presence of nozzle bypass struts will not significantly affect the acousticn noise reduction features of a General Electric type nozzle design. A unique coannular plug nozzle flight acoustic spectral prediction method was identified and found to predict the measured results quite well. Special laser velocimeter and acoustic measurements were performed which have given new insights into the jet and shock noise reduction mechanisms of coannular plug nozzles with regard to identifying further benificial research efforts

VCE early acoustic test results of General Electric's high-radius ratio coannular plug nozzle

Results of variable cycle engine (VCE) early acoustic engine and model scale tests are presented. A summary of an extensive series of far field acoustic, advanced acoustic, and exhaust plume velocity measurements with a laser velocimeter of inverted velocity and temperature profile, high radius ratio coannular plug nozzles on a YJ101 VCE static engine test vehicle are reviewed. Select model scale simulated flight acoustic measurements for an unsuppressed and a mechanical suppressed coannular plug nozzle are also discussed. The engine acoustic nozzle tests verify previous model scale noise reduction measurements. The engine measurements show 4 to 6 PNdB aft quadrant jet noise reduction and up to 7 PNdB forward quadrant shock noise reduction relative to a fully mixed conical nozzle at the same specific thrust and mixed pressure ratio. The influences of outer nozzle radius ratio, inner stream velocity ratio, and area ratio are discussed. Also, laser velocimeter measurements of mean velocity and turbulent velocity of the YJ101 engine are illustrated. Select model scale static and simulated flight acoustic measurements are shown which corroborate that coannular suppression is maintained in forward speed

Free-jet acoustic investigation of high-radius-ratio coannular plug nozzles. Comprehensive data report, volume 2

Laser velocimeter data, collected as part of an acoustic investigation of coannular plug nozzles, is provided. The type of traverse, position, and histogram number is given along with the mean and turbulent velocity data. The velocites are normalized with respect to the outer flow velocity and the 'mixed' velocity

Mortality and pulmonary complications in patients undergoing surgery with perioperative sars-cov-2 infection: An international cohort study

Background The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (740%) had emergency surgery and 280 (248%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (261%) patients. 30-day mortality was 238% (268 of 1128). Pulmonary complications occurred in 577 (512%) of 1128 patients; 30-day mortality in these patients was 380% (219 of 577), accounting for 817% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 175 [95% CI 128-240], p<00001), age 70 years or older versus younger than 70 years (230 [165-322], p<00001), American Society of Anesthesiologists grades 3-5 versus grades 1-2 (235 [157-353], p<00001), malignant versus benign or obstetric diagnosis (155 [101-239], p=0046), emergency versus elective surgery (167 [106-263], p=0026), and major versus minor surgery (152 [101-231], p=0047). Interpretation Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28–2·40], p\textless0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65–3·22], p\textless0·0001), American Society of Anesthesiologists grades 3–5 versus grades 1–2 (2·35 [1·57–3·53], p\textless0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01–2·39], p=0·046), emergency versus elective surgery (1·67 [1·06–2·63], p=0·026), and major versus minor surgery (1·52 [1·01–2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research

Long-term effectiveness of irreversible electroporation in a murine model of colorectal liver metastasis

Irreversible electroporation (IRE) has recently gained in popularity as an ablative technique, however little is known about its oncological long-term outcomes. To determine the long-time survival of animals treated with a high dose of IRE and which histological changes it induces in tumoral tissue, IRE ablation was performed in forty-six athymic-nude mice with KM12C tumors implanted in the liver by applying electric current with different voltages (2000 V/cm, 1000 V/cm). The tumors were allowed to continue to grow until the animals reached the end-point criteria. Histology was harvested and the extent of tumor necrosis was semi-quantitatively assessed. IRE treatment with the 2000 V/cm protocol significantly prolonged median mouse survival from 74.3 ± 6.9 days in the sham group to 112.5 ± 15.2 days in the 2000 V/cm group. No differences were observed between the mean survival of the 1000 V/cm and the sham group (83.2 ± 16.4 days, p = 0.62). Histology revealed 63.05% ± 23.12 of tumor necrosis in animals of the 2000 V/cm group as compared to 17.50% ± 2.50 in the 1000 V/cm group and 25.6% ± 22.1 in the Sham group (p = 0.001). IRE prolonged the survival of animals treated with the highest electric field (2000 V/cm). The animals in this group showed significantly higher rate of tumoral necrosis.This research was supported by the spanish government under grants TEC2011-27133-c02 and TEC2010-17285, and by the spanish “plan estatal de investigación, desarrollo e innovación orientada a los retos de la sociedad” under grant TEC2014–52383-c3-r (TEC2014–52383-c3-2-r and TEC2014–52383-c3-3-r)